NADPH oxidase stimulator (National Institute of Allergy and Infectious Diseases)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNADPH oxidase stimulator (National Institute of Allergy and Infectious Diseases)
Drug Alias Nameautologous gp91 granulocyte-enriched cells (NIAID)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionNADPH oxidase stimulants
TargetsNADPH oxidase
Therapy Area/IndicationsGranulomatous Disease, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsGranulomatous Disease, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A